Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LLY

Lilly(Eli) & Co

Jun 01 • 02:05PM ET

1,075.49

-29.51 -2.67 %

Healthcare • Drug Manufacturers - General • USA • Mega • NYSE

May 31, 8:05 AMEli Lilly's Retevmo cuts recurrence or death risk 83% in Phase 3 LIBRETTO-432 early-stage RET+ NSCLC trial

Peers: NVO PFE MRK ABBV JNJ BMY AZN NVS AMGN SNY

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF VHT SPYM

Scroll to Statements

Index	S&P 500	P/E	38.71	EPS (ttm)	27.78	Insider Own	10.04%	Shs Outstand	943.50M	Perf Week	0.98%
Market Cap	1012.83B	Forward P/E	24.14	EPS next Y	44.56	Insider Trans	-0.33%	Shs Float	847.20M	Perf Month	15.07%
Enterprise Value	1050.92B	PEG	0.85	EPS next Q	8.81	Inst Own	75.06%	Short Float	1.00%	Perf Quarter	5.65%
Income	25.27B	P/S	14.02	EPS this Y	51.04%	Inst Trans	-0.40%	Short Ratio	2.71	Perf Half Y	-2.61%
Sales	72.25B	P/B	32.53	EPS next Y	21.85%	ROA	24.54%	Short Interest	8.43M	Perf YTD	0.08%
Book/sh	33.07	P/C	191.75	EPS next 5Y	28.47%	ROE	107.64%	52W High	1149.10 -6.41%	Perf Year	45.80%
Cash/sh	5.61	P/FCF	85.67	EPS past 3/5Y	49.25% 27.59%	ROIC	35.82%	52W Low	623.78 72.41%	Perf 3Y	146.40%
Dividend Est.	7.13 (0.66%)	EV/EBITDA	29.02	Sales past 3/5Y	31.69% 21.58%	Gross Margin	82.83%	Volatility	3.13% 3.10%	Perf 5Y	442.03%
Dividend TTM	6.46 (0.60%)	EV/Sales	14.55	EPS Y/Y TTM	130.02%	Oper. Margin	47.30%	ATR (14)	33.07	Perf 10Y	1335.13%
Dividend Ex-Date	May 15, 2026	Quick Ratio	1.10	Sales Y/Y TTM	47.44%	Profit Margin	34.98%	RSI (14)	61.99	Recom	1.52
Dividend Gr. 3/5Y	15.24% 15.18%	Current Ratio	1.50	EPS Q/Q	169.45%	SMA20	5.23%	Beta	0.53	Target Price	1254.96
Payout	26.14%	Debt/Eq	1.39	Sales Q/Q	55.55%	SMA50	12.31%	Rel Volume	0.63	Prev Close	1105.00
Employees	50000	LT Debt/Eq	1.26	Earnings	Apr 30 BMO	SMA200	14.47%	Avg Volume	3.11M	Price	1075.49
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.64% 11.11%	Trades		Volume	1,401,719	Change	-2.67%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-17-26	Downgrade	HSBC Securities	Hold → Reduce	$850
Feb-25-26	Initiated	RBC Capital Mkts	Outperform	$1250
Feb-20-26	Initiated	Barclays	Overweight	$1350
Jan-07-26	Resumed	UBS	Buy	$1250
Dec-16-25	Upgrade	Daiwa Securities	Neutral → Buy	$1230
Dec-15-25	Reiterated	Goldman	Buy	$951 → $1145
Dec-15-25	Reiterated	BofA Securities	Buy	$1286 → $1268
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000

Show Previous Ratings

Today 01:20PM	Lilly's Retevmo Cuts Lung Cancer Recurrence Risk in Phase 3 Trial (GuruFocus.com)
06:16AM	Lilly and Hanmi sign $1.26bn licensing deal for sonefpeglutide (Pharmaceutical Technology)
05:37AM	Lilly Reports Strong Phase 3 Results for Retevmo in Early-Stage Lung Cancer (LLY) (InvestorsHub)
May-31-26 05:02PM	Could GLP-1 drugs become oncologys next big opportunity? (Investing.com)
09:53AM	Market concentration is creating 'fragility': Wall Street weighs 'narrow leadership' as stocks hit all-time high (Yahoo Finance)
09:53AM	Loading…
09:53AM	Market concentration is creating 'fragility': Only 60% of S&P 500 stocks are above their 200-day average (Yahoo Finance)
08:01AM	Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer (PR Newswire)
May-29-26 07:06PM	Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot (Barrons.com)
03:38PM	Eli Lilly Breaks Out Amid Vaccine Push; Three More Stocks At Highs (Investor's Business Daily)
10:22AM	Lilly Reopens Zepbound Access For 10 Million US Patients (GuruFocus.com)
06:00AM	Eli Lilly's $1 trillion valuation cements its status as Wall Street's ultimate weight-loss play (Yahoo Finance)
May-28-26 06:14PM	Eli Lilly Jumps as CVS Expands Weight-Loss Drug Coverage (GuruFocus.com)
06:07PM	CVS Restores Coverage for Lilly's Zepbound (GuruFocus.com)
05:17PM	Lilly Presses Ahead As $529 Billion Drug Pricing Fight Looms (GuruFocus.com)
05:16PM	S&P 500, Nasdaq And Dow Close At Record Highs Amid Positive Reports Of US-Iran Ceasefire Negotiations IBM, SNOW, CZR, AKTX, LLY In Focus (Stocktwits)
03:41PM	Loading…
03:41PM	Eli Lilly Back in $1 Trillion Club as Insurance Coverage Expands for Zepbound (The Wall Street Journal)
03:08PM	Lilly's GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans (MarketWatch)
02:07PM	CVS will add these weight-loss options to drug plans (USA TODAY)
01:55PM	Eli Lilly is on pace for its first record close of 2026 (MarketWatch)
01:00PM	Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care (PR Newswire)
12:54PM	LLY Stock Hits All-Time High CVS Coverage Boost For Zepbound May Be Driving Gains (Stocktwits)
12:37PM	Eli Lilly Stock Heads for Record Close. CVS Weight-Loss Drug Coverage Drives It Higher. (Barrons.com)
08:50AM	Eli Lilly shares edge higher after CVS expands coverage for Zepbound obesity drug (LLY) (InvestorsHub)
07:33AM	Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President (Reuters)
07:30AM	CVS Caremark is reversing course on Eli Lilly's weight loss drugs, adding both its shot and new pill to coverage (Quartz)
07:20AM	CVS Caremark adds Zepbound and Foundayo to insurance coverage (Quartz)
06:49AM	CVS brings back coverage for Lilly's obesity drug Zepbound (Reuters)
06:45AM	Foundayo and Zepbound now covered for millions of Americans (PR Newswire)
04:48AM	LLY, NVO Stocks Led Mays GLP-1 Rally But This Smaller Differentiated Player Got A Bold 160% Upside Call (Stocktwits)
May-27-26 12:00PM	A New, Powerful Cholesterol-Lowering Drug Is on the Horizon (The Wall Street Journal)
11:15AM	Loading…
11:15AM	Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire)
09:37AM	Lilly Goes on $20 Billion Buying Spree as It Seeks Next Act (Bloomberg)
07:45AM	Kaileras three-pronged obesity shot shows promise in early trial (BioPharma Dive)
12:43AM	HIMS Stock Heads For Weekly Loss But Ex-Netflix CFO Is Buying The Dip Despite BofAs GLP-1 Warning (Stocktwits)
May-26-26 05:38PM	S&P 500, Nasdaq Close At Record Highs Amid Hopes Of Diplomatic Resolution Between US And Iran MU, QCOM, LUNR, LLY, CODX In Focus (Stocktwits)
05:38PM	S&P 500 And Nasdaq Close At Record Highs, Dow Climbs Amid Hopes Of Diplomatic Resolution Between US And Iran MU, QCOM, LUNR, LLY, CODX In Focus (Stocktwits)
04:19PM	Eli Lilly Goes On A $3.83 Billion Acquisition Spree. Where's It Pushing Now? (Investor's Business Daily)
04:08PM	S&P 500 Hits Record High as Iran Peace Hopes Hold: Markets Wrap (Bloomberg)
03:44PM	Micron's valuation hits $1T, nearly tied with Eli Lilly & Berkshire (Yahoo Finance Video)
02:17PM	Lilly Targets Vaccines With $3.8 Billion Acquisition Push (GuruFocus.com)
02:17PM	BofA revamps Eli Lilly stock price target for rest of 2026 (GuruFocus.com)
12:47PM	Lilly Reports Strong Early Cholesterol Data (GuruFocus.com)
12:47PM	Lilly Expands Vaccine Push With $4 Billion Deal Spree (GuruFocus.com)
12:03PM	Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms (Proactive)
09:44AM	Micron briefly tops $1 trillion in market cap as UBS sees company becoming an AI giant (Yahoo Finance)
09:28AM	Eli Lilly to buy trio of vaccine developers in $3.8bn outlay (Pharmaceutical Technology)
09:25AM	Novo Nordisk and Eli Lilly Just Delivered Potential Breakthrough for Cancer Patients (GuruFocus.com)
08:25AM	LLY Stock Back In Spotlight After Sealing 10th Acquisition This Year Expands Beyond Obesity With $3.8B Vaccine Bet (Stocktwits)
08:00AM	Lilly Advances Gene Therapy, Snaps Up Vaccine Makers. It's Looking Beyond Weight Loss. (Barrons.com)
07:15AM	Eli Lilly acquires three vaccine developers for $3.8 billion (Quartz)
06:45AM	Lilly announces three acquisitions to build infectious disease portfolio (PR Newswire)
06:35AM	Lilly Agrees to Buy Trio of Vaccine Developers (The Wall Street Journal)
01:08AM	Eli Lilly Stock Eyes Best Month This Year As Cholesterol, Obesity Drug Tailwinds Build (Stocktwits)
May-25-26 02:38PM	Eli Lilly weight loss drug data supports long-term obesity market position, says UBS (Proactive)
08:45AM	A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia (PR Newswire)
May-22-26 04:45PM	How Eli Lilly is unlocking the next level for weight-loss drugs (Yahoo Finance Video)
11:04AM	Novo Nordisk faces new GLP-1 rival as Eli Lilly's triple agonist sets weight-loss record (Proactive)
08:02AM	Lilly and Novo Weight-Loss Drugs Show Potential Cancer Benefits (GuruFocus.com)
07:32AM	Lillys triple G agonist triumphs in Phase III trial, but AEs unnerve analysts (Clinical Trials Arena)
04:53AM	Whos winning pharmas innovation race? The rankings are out. (Pharma Voice)
May-21-26 05:00PM	Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting (PR Newswire)
02:41PM	Lilly Obesity Drug Shows 28% Weight Loss (GuruFocus.com)
02:09PM	Eli Lilly Obesity Drug Delivers Up to 28.3% Weight Loss (GuruFocus.com)
12:15PM	Canada and India now have generic Wegovy. Here's why the U.S. doesn't. (MarketWatch)
09:56AM	Eli Lilly's New GLP-1 Drug Looks Like a Weight-Loss Powerhouse in New Trial (Barrons.com)
09:45AM	Eli Lilly is buying gene therapy biotech Engage Bio for up to $202 million (Quartz)
09:34AM	New weight-loss shot more powerful than old GLP-1s, Eli Lilly says (USA TODAY)
09:20AM	Eli Lilly acquires Engage Biologics for up to $202 million (Quartz)
09:18AM	Eli Lilly's Next-Gen Obesity Drug Delivers Eye-Popping Weight Loss (Investor's Business Daily)
08:49AM	Eli Lilly shares rise after strong late-stage obesity drug trial results (LLY) (InvestorsHub)
08:11AM	Lilly's new experimental shot produced 28% weight loss (MarketWatch)
07:22AM	Eli Lilly maintains M&A streak with $202m Engage Bio buyout (Pharmaceutical Technology)
07:10AM	Eli Lilly's New Weight-Loss Treatment Shows Promising Results (The Wall Street Journal)
06:45AM	Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial (PR Newswire)
06:42AM	Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends (Medical Device Network)
06:07AM	Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say (Reuters)
01:00AM	Live Longer and Better. Does Medicine's New Obsession Really Work? (Barrons.com)
May-20-26 02:14PM	Denmark GDP Jumps 1.9% as Pharma Sector Drives Growth (GuruFocus.com)
10:05AM	These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally (MarketWatch)
07:48AM	Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery (Reuters)
05:45AM	CEOs Are Getting Ruthless About Worker Performance (Bloomberg)
May-19-26 11:55PM	Lilly snaps up Engage to advance non-viral genetic medicines (BioPharma Dive)
May-18-26 01:30PM	Some people lose far more weight than others on GLP-1s like Wegovy. Here's why. (MarketWatch)
01:13PM	Eli Lilly's Obesity Boom Leaves Little Room for Error (GuruFocus.com)
10:00AM	Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference (PR Newswire)
09:02AM	AstraZeneca Wins FDA Approval for $5 Billion Blood Pressure Drug (GuruFocus.com)
08:25AM	Novo Nordisk Eyes Global Push for Wegovy Pill (GuruFocus.com)
08:05AM	Novo Nordisk's Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says (Proactive)
05:21AM	Race intensifies to lead next wave of obesity drugs as trial results loom (Pharma Voice)
May-16-26 11:00AM	Lilly, Caitlin Clark Foundation, and Musco Lighting open three community sports courts in Indianapolis, expanding year-round access for youth (PR Newswire)
May-14-26 06:15PM	Imvivas CTA313 Lupus Drug Shows Promising Remission Results (Exec Edge)
07:00AM	Lilly and UNICEF collaborate to give millions of children a healthier start (PR Newswire)
May-13-26 07:02AM	It's a Growth Stock World-and Nothing Is Going to Change That (Barrons.com)
06:00AM	Ahold Delhaizes latest SVP appointment signals stateside AI growth (Grocery Dive)
May-12-26 06:01PM	Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials (PR Newswire)
12:50PM	Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In Obesity (Investor's Business Daily)
12:17PM	Google AI legend raises big money for startup targeting this cutting-edge goal (MarketWatch)
12:00PM	In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries (PR Newswire)
07:42AM	Pharmas manufacturing reconfigurations provide CDMOs with expansion opportunities (Pharmaceutical Technology)
May-11-26 06:00PM	PRIMECAP Management's Strategic Moves: AstraZeneca PLC Exits with a -2.57% Impact (GuruFocus.com)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

MBADavid A. Ricks

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LILLY ENDOWMENT, INC.	Shareholder	May 28 '26	Proposed Sale	1082.92	310,000	335,705,200		May 28 03:02 PM
LILLY ENDOWMENT, INC.	Shareholder	May 22 '26	Proposed Sale	1041.65	300,000	312,495,000		May 22 02:05 PM
LILLY ENDOWMENT, INC.	Shareholder	May 20 '26	Proposed Sale	1021.41	305,000	311,530,050		May 20 04:22 PM
LILLY ENDOWMENT INC	Former 10% Shareholder	May 06 '26	Sale	995.36	15,828	15,754,537	91,881,150	May 07 04:00 PM
LILLY ENDOWMENT, INC.	Shareholder	May 06 '26	Proposed Sale	988.87	300,000	296,661,000		May 06 04:35 PM
Zakrowski Donald A	SVP, Finance, & CAO	Feb 16 '26	Option Exercise	0.00	184	0	3,607	Feb 18 04:22 PM
Montarce Lucas	EVP & CFO	Feb 16 '26	Option Exercise	0.00	368	0	16,418	Feb 18 04:21 PM
Custer Kenneth L.	EVP & President, Card Met Hlth	Feb 16 '26	Option Exercise	0.00	207	0	10,232	Feb 18 04:21 PM
Brown Adrienne S	EVP, President LLY Imm	Feb 16 '26	Option Exercise	0.00	391	0	5,312	Feb 18 04:19 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Feb 01 '26	Option Exercise	0.00	3,394	0	29,654	Feb 03 04:32 PM
Skovronsky Daniel	EVP, CS&PO & Pres. LRL	Feb 01 '26	Option Exercise	0.00	12,684	0	150,165	Feb 03 04:31 PM
Van Naarden Jacob	EVP,Pres LLY Oncology&HdCorpBD	Feb 01 '26	Option Exercise	0.00	4,108	0	24,670	Feb 03 04:31 PM
Ricks David A	President, Chair, and CEO	Feb 01 '26	Option Exercise	0.00	31,932	0	547,098	Feb 03 04:29 PM
Rau Diogo	EVP & CIDO	Feb 01 '26	Option Exercise	0.00	3,752	0	23,471	Feb 03 04:28 PM
Jonsson Patrik	EVP & President, LLY Int'l	Feb 01 '26	Option Exercise	0.00	3,930	0	57,581	Feb 03 04:27 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '26	Option Exercise	0.00	3,572	0	43,303	Feb 03 04:26 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '26	Option Exercise	0.00	6,700	0	17,662	Feb 03 04:25 PM
Dozier Eric	EVP, Chief People Officer	Feb 01 '26	Option Exercise	0.00	2,858	0	12,697	Feb 03 04:24 PM
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your Finviz experience